India Synthesizes Rare Anti-Doping Reference Material for Global Use

In a groundbreaking scientific achievement, India has developed a rare anti-doping reference material—Methandienone Long-Term Metabolite (LTM)—to strengthen drug testing mechanisms in sports. This effort is the result of a strategic collaboration between the National Institute of Pharmaceutical Education and Research (NIPER) Guwahati and the National Dope Testing Laboratory (NDTL), New Delhi, under the Department of Pharmaceuticals. The initiative places India among a small group of nations capable of synthesizing such highly specialized materials, furthering the global cause of clean sports.

What Are Reference Materials and Why They Matter

Reference Materials (RMs) are ultra-purified chemical substances or their metabolites used for accurate analytical testing. In anti-doping contexts, these materials help labs,

• Detect banned substances listed by the World Anti-Doping Agency (WADA)
• Ensure high-precision results in athlete drug tests
• Maintain transparency and reliability in testing processes

Only 4–5 institutions globally produce these rare RMs, making them both costly and hard to access. India’s ability to now synthesize them domestically marks a major scientific and strategic milestone.

Launch of Methandienone LTM: A Game-Changer in Sports Testing

• The Methandienone Long-Term Metabolite was officially launched on September 4, 2025, by Dr. Mansukh Mandaviya, Union Minister for Youth Affairs & Sports, during the 22nd Governing Body Meeting of NDTL in New Delhi.
• This particular metabolite is used to detect the use of Methandienone, an anabolic steroid often misused by athletes to gain strength and muscle mass. What sets LTMs like this apart is their ability to stay in the body for extended periods, allowing detection even months or years after the last usage.

Key features of Methandienone LTM

• Not commercially available globally
• Tracks long-term steroid use through urine testing
• Strengthens deterrence by increasing positive test rates
• Supports anti-doping enforcement with scientific accuracy

NIPER-NDTL Collaboration: Building India’s Doping Detection Capacity

Since 2020, NIPER Guwahati and NDTL have been working together to create 22 non-commercial RMs crucial for anti-doping analysis. So far, 12 of these have already been synthesized, with Methandienone LTM being the latest.

This project shows India’s commitment to,

• Scientific innovation in public health and sports integrity
• Contributing to international anti-doping labs, especially the 30 WADA-accredited labs worldwide
• Reducing dependency on expensive imports from Western manufacturers
• By doing so, India not only strengthens its domestic testing ecosystem but also becomes a global supplier of essential doping control tools.

Global Significance and Future Impact

The development of Methandienone LTM offers multiple benefits,

• Empowers clean athletes by ensuring fair play
• Acts as a powerful deterrent to those considering doping
• Positions India as a scientific contributor to WADA’s global network
• Opens opportunities for research, collaboration, and leadership in anti-doping sciences

This step also aligns with India’s broader sports vision under initiatives like Fit India and efforts to promote ethics and accountability in athletics.

Key Takeaways for Exam

• India developed Methandienone Long-Term Metabolite (LTM) in September 2025.
• Jointly created by NIPER Guwahati and NDTL, under the Department of Pharmaceuticals.
• Reference Material will aid detection of anabolic steroid Methandienone months after usage.